Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA 01 - SCLC: Research Perspectives

    • 11:00 - 12:30
    • 10/16/2017
    • Location: Room 503
    • Type: Mini Oral
    • Track: SCLC/Neuroendocrine Tumors
  • +

    P2.04 - Clinical Design, Statistics and Clinical Trials

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • +

      P2.04-001 - BALTIC: A Phase 2, Open-Label Study of Novel Combinations of Immunotherapies or DDR Inhibitors in Platinum-Refractory ED-SCLC

      09:30 - 09:30  |  Presenter: Ihor Vynnychenko  |  Author(s): H. Jiang, Y. Huang, P.A. Dennis, J. Von Pawel

      • Abstract

      Loading...

    • +

      P2.04-002 - CASPIAN: Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Platinum-Based Chemotherapy vs Chemotherapy Alone in ED-SCLC

      09:30 - 09:30  |  Presenter: Luis Paz-Ares  |  Author(s): H. Jiang, Y. Huang, P.A. Dennis

      • Abstract

      Loading...

  • +

    P3.01 - Advanced NSCLC

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • +

      P3.01-025 - Treatment Outcomes of Advanced Lung Adenocarcinoma with Unknown EGFR Gene Status: A Retrospective Analysis of 140 Patients

      09:30 - 09:30  |  Presenter: Cheng Xiao  |  Author(s): L.Y. Zheng, C. Mao, H. Jiang, J. Qian, N. Xu

      • Abstract

      Loading...

  • +

    P3.02 - Biology/Pathology

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Biology/Pathology
  • +

    P3.04 - Clinical Design, Statistics and Clinical Trials

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • +

      P3.04-005 - PD-L1 and Other Immuno-Markers Influenced by Osimertinib Treatment in Advanced Non-Small Cell Lung Cancer Patients (ATHENE Study)

      09:30 - 09:30  |  Presenter: Shun Lu  |  Author(s): Yongfeng Yu, H. Jian

      • Abstract

      Loading...